SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-017211
Filing Date
2018-03-06
Accepted
2018-03-06 16:14:58
Documents
1
Period of Report
2018-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2932
  Complete submission text file 0001209191-18-017211.txt   4350
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
McClellan Michael James (Reporting) CIK: 0001721544 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-16174 | Film No.: 18670044